Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROCHLOROTHIAZIDE 12.5MG TABLET Resolved 2024-03-22 2024-04-26 223083
OLMESARTAN/HCTZ 40MG 25MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223370
OLMESARTAN/HCTZ 40MG 12.5MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223383
OLMESARTAN/HCTZ 20MG 12.5MG TABLET Anticipated shortage 2024-03-26 2024-05-08 223386
SANDOZ LISINOPRIL HCT 25MG 20MG TABLET Actual shortage 2024-04-08 2024-04-09 224639
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Actual shortage 2024-04-11 2024-05-23 224895
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Actual shortage 2024-04-11 2024-05-23 224898
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Actual shortage 2024-04-11 2024-05-23 224901
CANDESARTAN/HCTZ 12.5MG 16MG TABLET Actual shortage 2024-04-22 2024-04-23 225881
CANDESARTAN-HCTZ 12.5MG 16.0MG TABLET Resolved 2024-05-03 2024-05-16 227037

Showing 661 to 670 of 674

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALTACE HCT 12.5MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214024
ALTACE HCT 25MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214027

Showing 101 to 102 of 102